secwatch.observer — SEC 8-K summary ====================================== Issuer: TELA Bio, Inc. (TELA) CIK: 0001561921 Form: 8-K Filed at: 2023-10-20T23:59:59+00:00 Accession: 0001104659-23-110478 Event type: other_material Sentiment: neutral Materiality: 0.30 Item codes: 1.01 LLM model: deepseek-v4-flash:cloud@v2 TELA Bio extends HQ lease to 2030, adds 15,881 sq ft of space ------------------------------------------------------------- - Entered Fourth Amendment to Lease for corporate headquarters in Malvern, PA. - Lease term extended from May 31, 2028 to May 31, 2030. - Adds 15,881 sq ft from Dec 1, 2023, total leased to 40,606 sq ft; will later reduce by 4,652 sq ft on June 30, 2025. - Monthly base rent starts at $49,403.97, increases annually; after July 2025 base rent $45,841.35. - Space houses R&D, controlled environment room, and office operations. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465923110478/0001104659-23-110478-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1561921/000110465923110478/tm2328833d1_8k.htm HTML page: https://secwatch.observer/filing/0001104659-23-110478 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer